Core Insights - The company, Yejun Medical Group Holdings Limited, received the "Annual Outstanding Overseas Award" at the 2025 Golden Award for Excellence, highlighting its international influence and achievements in cross-border cooperation [1][3]. Group 1 - Yejun Medical has been dedicated to developing innovative interventional treatment solutions for over 20 years, establishing a global network with R&D, manufacturing, and logistics bases in China, Japan, Germany, and the Netherlands [1]. - The company has a strong sales engine consisting of 14 direct sales teams and over 300 distributors across various countries, enabling it to deliver innovative medical devices to over 70 countries and regions [1]. - The award recognizes companies that efficiently allocate global resources and integrate deeply into international industrial chains, enhancing the brand value, pricing power, and industry voice of Chinese enterprises in the global market [1].
业聚医疗(6929.HK)荣获格隆汇 2025 年度"金格奖"之"年度卓越出海奖"